Literature DB >> 20682873

Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.

Ghislain Emmanuel Sopoh1, Ange Dodji Dossou, Luc Valère Brun, Yves Thierry Barogui, Jean Gabin Houézo, Dissou Affolabi, Séverin Y Anagonou, Roch Christian Johnson, Luc Kestens, Françoise Portaels.   

Abstract

Buruli ulcer (BU), a disease caused by Mycobacterium ulcerans, leads to the destruction of skin and sometimes bone. Here, we report a case of severe multifocal BU with osteomyelitis in a 6-year-old human immunodeficiency virus (HIV)-negative boy. Such disseminated forms are poorly documented and generally occur in patients with HIV co-infection. The advent of antibiotic treatment with streptomycin (S) and rifampin (R) raised hope that these multifocal BU cases could be reduced. The present case raises two relevant points about multifocal BU: the mechanism of dissemination that leads to the development of multiple foci and the difficulties of treatment of multifocal forms of BU. Biochemical (hypoproteinemia), hematological (anemia), clinical (traditional treatment), and genetic factors are discussed as possible risk factors for dissemination.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682873      PMCID: PMC2911176          DOI: 10.4269/ajtmh.2010.09-0617

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  29 in total

1.  Disseminated Mycobacterium ulcerans disease in an HIV-positive patient: a case study.

Authors:  R Christian Johnson; David Ifebe; Aristote Hans-Moevi; Luc Kestens; Raoul Houessou; Augustin Guédénon; Wayne M Meyers; Françoise Portaels
Journal:  AIDS       Date:  2002-08-16       Impact factor: 4.177

2.  [On a case of abscess due to Mycobacterium fortuitum].

Authors:  P LIMBOS; J BRETEY; J JADIN; P BRUTSAERT
Journal:  Ann Soc Belg Med Trop (1920)       Date:  1961-04-30

3.  Leprosy after starting antiretroviral treatment.

Authors:  Stephen D Lawn; Diana N J Lockwood
Journal:  BMJ       Date:  2007-02-03

4.  Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy.

Authors:  Luc Kestens; Nabila Seddiki; Paul R Bohjanen
Journal:  Curr Opin HIV AIDS       Date:  2008-07       Impact factor: 4.283

5.  Healthcare seeking behaviour for Buruli ulcer in Benin: a model to capture therapy choice of patients and healthy community members.

Authors:  Annelies A Mulder; Roelien P Boerma; Yves Barogui; Claude Zinsou; R Christian Johnson; Jules Gbovi; Tjip S van der Werf; Ymkje Stienstra
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-07-09       Impact factor: 2.184

6.  [Multifocal forms of Buruli ulcer: clinical aspects and management difficulties in 11 cases].

Authors:  D Ouattara; J P Meningaud; F Saliba
Journal:  Bull Soc Pathol Exot       Date:  2002-11

7.  Buruli ulcer: a systemic disease.

Authors:  Nina Pszolla; Michael Robindra Sarkar; Wolf Strecker; Peter Kern; Lothar Kinzl; Wayne M Meyers; Françoise Portaels
Journal:  Clin Infect Dis       Date:  2003-08-26       Impact factor: 9.079

8.  Protein-energy malnutrition modifies the production of interleukin-10 in response to lipopolysaccharide (LPS) in a murine model.

Authors:  Ricardo Ambrósio Fock; Marco Aurélio Ramirez Vinolo; Amanda Rabello Crisma; Karina Nakajima; Marcelo Macedo Rogero; Primavera Borelli
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  2008-10       Impact factor: 2.000

9.  Histopathologic features of Mycobacterium ulcerans infection.

Authors:  Jeannette Guarner; Jeanine Bartlett; Ellen A Spotts Whitney; Pratima L Raghunathan; Ymkje Stienstra; Kwame Asamoa; Samuel Etuaful; Erasmus Klutse; Eric Quarshie; Tjip S van der Werf; Winette T A van der Graaf; C Harold King; David A Ashford
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

10.  Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin.

Authors:  Daniela Schütte; Alphonse Um-Boock; Ernestina Mensah-Quainoo; Peter Itin; Peter Schmid; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2007-10-31
View more
  11 in total

Review 1.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

2.  Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.

Authors:  Alexandra G Fraga; Andrea Cruz; Teresa G Martins; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Wayne M Meyers; Françoise Portaels; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?

Authors:  Marie-Thérèse Ruf; Annick Chauty; Ambroise Adeye; Marie-Françoise Ardant; Hugues Koussemou; Roch Christian Johnson; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2011-08-02

4.  Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection.

Authors:  Teresa G Martins; José B Gama; Alexandra G Fraga; Margarida Saraiva; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

5.  Impact of human immunodeficiency virus on the severity of buruli ulcer disease: results of a retrospective study in cameroon.

Authors:  Vanessa Christinet; Eric Comte; Laura Ciaffi; Peter Odermatt; Micaela Serafini; Annick Antierens; Ludovic Rossel; Alain-Bertrand Nomo; Patrick Nkemenang; Akoa Tsoungui; Cecile Delhumeau; Alexandra Calmy
Journal:  Open Forum Infect Dis       Date:  2014-05-21       Impact factor: 3.835

6.  Clinical Epidemiology of Buruli Ulcer from Benin (2005-2013): Effect of Time-Delay to Diagnosis on Clinical Forms and Severe Phenotypes.

Authors:  Carlos Capela; Ghislain E Sopoh; Jean G Houezo; René Fiodessihoué; Ange D Dossou; Patrício Costa; Alexandra G Fraga; João F Menino; Rita Silva-Gomes; Edgard M Ouendo; Fernando Rodrigues; Jorge Pedrosa
Journal:  PLoS Negl Trop Dis       Date:  2015-09-10

7.  Multifocal Buruli Ulcer Associated with Secondary Infection in HIV Positive Patient.

Authors:  Kassi Komenan; Ecra J Elidjé; Gbery P Ildevert; Kouassi I Yao; Kouame Kanga; Kouassi A Kouamé; Sangaré Abdoulaye; Kourouma S Hamdam; Yoboué P Yao; Kanga Jean-Marie
Journal:  Case Rep Med       Date:  2013-12-25

8.  Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection.

Authors:  Teresa G Martins; Gabriela Trigo; Alexandra G Fraga; José B Gama; Adhemar Longatto-Filho; Margarida Saraiva; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29

9.  Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model.

Authors:  Gabriela Trigo; Teresa G Martins; Alexandra G Fraga; Adhemar Longatto-Filho; António G Castro; Joana Azeredo; Jorge Pedrosa
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25

10.  Burden and Historical Trend of Buruli Ulcer Prevalence in Selected Communities along the Offin River of Ghana.

Authors:  Kobina Assan Ampah; Prince Asare; Daniel De-Graft Binnah; Samuel Maccaulley; William Opare; Katharina Röltgen; Gerd Pluschke; Dorothy Yeboah-Manu
Journal:  PLoS Negl Trop Dis       Date:  2016-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.